/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Michel Fabbro

Université de Montpellier(FR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

422

Papers

11.7K

Citations

52

h-index

121

i10-index

Michel Fabbro is an academic researcher from Université de Montpellier. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & PARP inhibition in cancer therapy & Glioma Diagnosis and Treatment. The author has an h-index of 52, co-authored 359 publications.

ORCID: 0000-0003-1910-4777

Research Topics

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Glioma Diagnosis and Treatment BRCA gene mutations in cancer Endometrial and Cervical Cancer Treatments

Papers by this author

works

Lomustine and Bevacizumab in Progressive Glioblastoma

2017 · New England Journal of Medicine · 949 citations

https://doi.org/10.1056/nejmoa1707358

Wolfgang Wick Thierry Gorlia Martin Bendszus Martin Taphoorn

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

2009 · Breast Cancer Research · 176 citations

https://doi.org/10.1186/bcr2326

Catherine Alix‐Panabières Jean-Pierre Vendrell Monique Slijper Olivier Pellé

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO

2013 · British Journal of Cancer · 102 citations

https://doi.org/10.1038/bjc.2013.183

Isabelle Ray‐Coquard Laure Favier B. Weber C. Roemer-Bécuwe

Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site

2020 · British Journal of Cancer · 85 citations

https://doi.org/10.1038/s41416-020-01153-4

Maud Kamal Sonia Lameiras Marc Deloger Adeline Morel

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)

1999 · British Journal of Cancer · 62 citations

https://doi.org/10.1038/sj.bjc.6690714

Patrice Viens T Palangié Maud Janvier Michel Fabbro

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

2023 · International Journal of Gynecological Cancer · 51 citations

https://doi.org/10.1136/ijgc-2023-004995

Domenica Lorusso Marie‐Ange Mouret‐Reynier Philipp Harter Claire Cropet

Research topics

topics

Ovarian cancer diagnosis and treatment

PARP inhibition in cancer therapy

Glioma Diagnosis and Treatment

BRCA gene mutations in cancer

Endometrial and Cervical Cancer Treatments

Chat about Author

Papers

Chat

Click to start Chat